Effect of 3 Single‐Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol‐O‐Methyltransferase Activity and Motor Response in Patients With Parkinson Disease

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 3, 2016-05 ,pp. : 232-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease

By Lemay S.   Chouinard S.   Blanchet P.   Masson H.   Soland V.   Beuter A.   Bedard M.-A.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Treatment options for non-motor symptoms in late-stage Parkinson's disease

By Coelho Miguel   Ferreira Joaquim   Rosa Mrio   Sampaio Cristina  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 523-535

Informa Healthcare

Access to resources Recommend Favorite

Drug treatment of non-motor symptoms in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 381-388

Informa Healthcare

Access to resources Recommend Favorite

Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 670-684

Bentham Science Publishers

Access to resources Recommend Favorite